![Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7049a2-F.gif?_=85790)
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | MMWR
![CDC Approves Moderna, J&J and Pfizer COVID-19 Boosters; Appointments Available at PWHC | University of Arkansas CDC Approves Moderna, J&J and Pfizer COVID-19 Boosters; Appointments Available at PWHC | University of Arkansas](https://campusdata.uark.edu/resources/images/articles/2021-10-26_02-53-55-PM10258_UA_COVID19_vaccination_Pat_Walker_Health_Center-2-smalljpg.jpg)
CDC Approves Moderna, J&J and Pfizer COVID-19 Boosters; Appointments Available at PWHC | University of Arkansas
![FDA authorizes another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up - The Boston Globe FDA authorizes another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up - The Boston Globe](https://www.bostonglobe.com/resizer/HLBI3LkuIsay3s9wKRVa3Qezz6w=/arc-anglerfish-arc2-prod-bostonglobe/public/QVGD6XPZZ5L4Q6ABKNZWFSWMVQ.jpg)
FDA authorizes another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up - The Boston Globe
![Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 | MMWR Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7038e1-F-large.gif?_=07737)
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 | MMWR
![Moderna: futuro incerto per il settore, ma la tecnologia mRNA ha ancora un grande potenziale - Il Sole 24 ORE Moderna: futuro incerto per il settore, ma la tecnologia mRNA ha ancora un grande potenziale - Il Sole 24 ORE](https://i2.res.24o.it/images2010/S24/Documenti/2023/10/29/Immagini/Ritagli/moderna-1630083683-kHOG--1440x752@IlSole24Ore-Web.jpg)